C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/30 (2006.01) A61K 31/404 (2006.01) A61P 29/00 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2551168
The present invention relates to aniline derivatives of the general formula I and their use as serotonin reuptake inhibitors and preferably also norepinephrine reuptake inhibitors in the treatment of depression, anxiety, affective disorders, pain disorders, attention deficit hyperactivity disorder (ADHD) and stress urinary incontinence.
La présente invention concerne des dérivés d'aniline représentés par la formule générale (I) et leur utilisation comme inhibiteurs spécifiques de la recapture de la sérotonine et de préférence également comme inhibiteurs de la recapture de la noradrénaline dans le traitement de la dépression, de l'anxiété, des troubles affectifs, de la douleur, du trouble de déficit de l'attention/de l'hyperactivité (TDA/H) et de l'incontinence urinaire d'effort.
Bang Norgaard Morten
Juhl Karsten
Kehler Jan
Sejberg Jimmy
Goudreau Gage Dubuc
H. Lundbeck A/s
LandOfFree
2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1898671